Clever Culture Systems Limited has released a press release.
APAS Independence MRSA Study Results Presented at ECCMID
Filed with ASX ·
6ix hasn’t read this filing yet.
Clever Culture Systems Limited on 6ix
Earlier from Clever Culture Systems
- MRSA Analysis Module - Clinical Study Commenced
- US FDA 510k Submitted for APAS Independence
- LBT Presentation - 121 Tech Investment Conference, Singapore
- CEO Presentation - AGM 2018
- First Placement of APAS Independence into US Lab
Later from Clever Culture Systems
- Business Update Presentation
- South Australian Government Loan - $1.0M Drawdown
- APAS Independence Receives US FDA 510(k) Clearance
- $5M Oversubscribed Private Placement
- Information Required Under ASX Listing Rule 3.10.5A
Follow Clever Culture Systems into a list and get an email when it puts out news.
Follow Clever Culture Systems